Facebook icon.Twitter icon.RSS Feed.

Annual General Meeting 2016

You are here

Annual General Meeting

October 8, 2016
1:00 P.M – 2:30 P.M.

AGENDA

1:00 P.M. - 2:30 P.M.

1.      Approval of the Agenda
2.     
Introduction of the Current Board
3.      Approval of Minutes – AGM June 2015
4.      By-Law Amendments
5.      Approval of Audited Financial Statements (2015-2016)
6.      Appointment of Auditors for the 2016-17 Fiscal Year
7.      Election of 2016-17 Board of Directors

ACNL By-Law Amendment

Current Wording

6.04  Board Seats

There are a total of twelve (12) seats on the Board. Three (3) of the Board seats are designated for persons living with HIV/AIDS (“PHAs”), with the others seats being open or “non-designated” (i.e. may be occupied by PHAs or non-PHAs).

There is representation on the Board from all regions across Newfoundland and Labrador, broken down as follows:

  • 7 seats from the Avalon region: 2 designated PHA seats; 5 open seats
  • 1 seat from the Eastern Region
  • 1 seat from the Central region
  • 1 seat from the Western region
  • 1 seat from Labrador
  • 1 additional PHA seat (from any region other than the Avalon)

If no nomination is presented for a PHA designated seat, the nominations for that seat can be received from the general membership. Potential Directors (other than those holding the PHA designated seats) who are PHAs need not reveal their status to the Board.

Proposed New Wording

6.04 Board Seats

There are a total of twelve (12) seats on the Board. Three (3) of the Board seats are designated for persons living with HIV/HCV or those Affected, should no candidates presenting be persons living with HIV/HCV or Affected, with the others seats being open or “non-designated” (i.e. may be occupied by persons living with HIV/HCV or non-HIV/HCV).

There is representation on the Board from all regions across Newfoundland and Labrador, broken down as follows:

  • 7 seats from the Avalon region: 2 designated HIV/HCV or those Affected seats; 5 open seats
  • 1 seat from the Eastern Region
  • 1 seat from the Central region
  • 1 seat from the Western region
  • 1 seat from Labrador
  • 1 additional HIV/HCV or those Affected seat (from any region other than the Avalon)

If no nomination is presented for a HIV/HCV or those Affected designated seat, the nominations for that seat can be received from the general membership. Potential Directors (other than those holding the HIV/HCV or those Affected designated seats) who are HIV+ or HCV+ need not reveal their status to the Board.

 

Current Wording

6.08 Board Recruitment

Persons interested in joining the Board are required to complete an application, and forward it to the Executive Committee. The Executive Committee is responsible for reviewing all applications and bringing their recommendations forward to the rest of the Board regarding appointments to vacant seats. The Executive Committee also makes recommendations regarding which candidates the sitting Board wishes to endorse at any AGM election.

While the Corporation does accept nominations from the floor at the AGM, such nominees must outline their credentials and qualifications for directorship to the attending Members prior to a vote. If such a nominee is elected, and their credentials and qualifications cannot be substantiated by the Board, she or he will be subject to removal from the Board.

Proposed New Wording

6.08 Board Recruitment

Persons interested in joining the Board are required to complete an application, and forward it to the Executive Committee. The Executive Committee is responsible for reviewing all applications and bringing their recommendations forward to the rest of the Board regarding appointments to vacant seats. The Executive Committee also makes recommendations regarding which candidates the sitting Board wishes to endorse at any AGM election. The corporation does not accept nominations from the floor at the AGM. Nominations from the membership for Board seats must be received at least 30 days prior to the AGM at which time Board seats are ratified.

Upcoming

Contact Form

Please provide your full name.
Please provide an email address we can use to reach you
What is your question regarding?
Please type your message above